<p>The values are presented as the means ± SEM; n = 6 for each group. One (*), two (**) or three (***) indicate <i>p</i><0.05, <i>p</i><0.01 or <i>p</i><0.001 <i>vs</i> the TNF-α treated group, respectively; ### indicates <i>p</i><0.001 <i>vs</i> the control group.</p
<p>(A) Levels of p-IκBα with or without treatment in response to TNF-α were determined by western bl...
<p>FLS were treated exactly as described in the legend for <a href="http://www.plosone.org/article/i...
<p>A. NF-κB binding was significantly increased by LPS treatment. After treatment with P1 or MP12, N...
<p>A: Effects of the potential NF-κB inhibitors on the NF-κB expression. B and C: IL-6 and IL-8 expr...
<p>A: The expression of NF-κB in TNF-α stimulated HEK 293 cells. The values are presented as the mea...
<p><b>A</b>: The levels of NF-κB in TNF-α stimulated HEK 293 cells. Values are presented as the mean...
<p>(<b>A</b>) Effects of the potential NF-κB inhibitors by the dual-luciferase reporter assay system...
<p>Lymphocytes were isolated from three individuals (Subjects 1, 2 and 3) and treated with 10 ng/ml ...
<p>Results expressed as pg/ml of TNF-α in the BALF. Difference in the variance of the two groups is ...
<p>PC-3 cells were pretreated with α-tomatine for 30 minutes and followed by 10 ng/ml of TNF-α stimu...
<p>(A), Sa3 cells were incubated with or without 5 mg/mL of 5-FU for 1 h and 3 h. The cells then sta...
<p>(A) HEK293 cells stably expressing NF-κB luciferase reporter were pretreated with indicated small...
<p>Abbreviations: C—untreated cells; TNF—TNF-α-treated cells; E– 3 μM-escin-treated cells. The resul...
RAW264.7 cells were treated with the f NF-κB activation inhibitor and MAPKs activation inhibitors. A...
<p> (<b>A</b>) Variance accounted for by each of the principal components (PCs). (<b>B–D</b>) Scatte...
<p>(A) Levels of p-IκBα with or without treatment in response to TNF-α were determined by western bl...
<p>FLS were treated exactly as described in the legend for <a href="http://www.plosone.org/article/i...
<p>A. NF-κB binding was significantly increased by LPS treatment. After treatment with P1 or MP12, N...
<p>A: Effects of the potential NF-κB inhibitors on the NF-κB expression. B and C: IL-6 and IL-8 expr...
<p>A: The expression of NF-κB in TNF-α stimulated HEK 293 cells. The values are presented as the mea...
<p><b>A</b>: The levels of NF-κB in TNF-α stimulated HEK 293 cells. Values are presented as the mean...
<p>(<b>A</b>) Effects of the potential NF-κB inhibitors by the dual-luciferase reporter assay system...
<p>Lymphocytes were isolated from three individuals (Subjects 1, 2 and 3) and treated with 10 ng/ml ...
<p>Results expressed as pg/ml of TNF-α in the BALF. Difference in the variance of the two groups is ...
<p>PC-3 cells were pretreated with α-tomatine for 30 minutes and followed by 10 ng/ml of TNF-α stimu...
<p>(A), Sa3 cells were incubated with or without 5 mg/mL of 5-FU for 1 h and 3 h. The cells then sta...
<p>(A) HEK293 cells stably expressing NF-κB luciferase reporter were pretreated with indicated small...
<p>Abbreviations: C—untreated cells; TNF—TNF-α-treated cells; E– 3 μM-escin-treated cells. The resul...
RAW264.7 cells were treated with the f NF-κB activation inhibitor and MAPKs activation inhibitors. A...
<p> (<b>A</b>) Variance accounted for by each of the principal components (PCs). (<b>B–D</b>) Scatte...
<p>(A) Levels of p-IκBα with or without treatment in response to TNF-α were determined by western bl...
<p>FLS were treated exactly as described in the legend for <a href="http://www.plosone.org/article/i...
<p>A. NF-κB binding was significantly increased by LPS treatment. After treatment with P1 or MP12, N...